6/9/25 We are currently making changes to reflect the new Health Sciences Division structure. Thank you for your patience while we make the transition.

Sign in
Back
β-blockers in exacerbations of COPD: feasibility of a randomised controlled trial
Journal article   Open access   Peer reviewed

β-blockers in exacerbations of COPD: feasibility of a randomised controlled trial

Catherina L. Chang, Conroy Wong, Lutz Beckert, Eskandarain Shafuddin, Richard Beasley, Robert Young and Robert J. Hancox
ERJ open research, Vol.3(1), p.90
01/01/2017
DOI: https://doi.org/10.1183/23120541.00090-2016
Handle:
https://hdl.handle.net/10523/37617

Abstract

Original Research Letters
Cardiac diseases are a major cause of death in patients with chronic obstructive pulmonary disease (COPD). Acute cardiac events often occur during exacerbations of COPD, and even subclinical cardiac abnormalities are linked to a worse prognosis in this setting [1, 2]. A feasibility randomised controlled trial of β-blockers in acute exacerbations of COPD http://ow.ly/lVcy305B36D
url
https://doi.org/10.1183/23120541.00090-2016View
Published (Version of record) Open

Metrics

4 Record Views

Details

Logo image